Compare SLB & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLB | BDX |
|---|---|---|
| Founded | 1926 | 1897 |
| Country | United States | United States |
| Employees | 109000 | N/A |
| Industry | Oilfield Services/Equipment | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.9B | 51.5B |
| IPO Year | 1996 | 1994 |
| Metric | SLB | BDX |
|---|---|---|
| Price | $44.74 | $159.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 11 |
| Target Price | $52.11 | ★ $189.60 |
| AVG Volume (30 Days) | ★ 15.2M | 2.4M |
| Earning Date | 04-24-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.65% | 2.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | 1.34 |
| Revenue | ★ $30,440,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $5.44 | N/A |
| Revenue Next Year | $4.58 | $2.53 |
| P/E Ratio | ★ $18.95 | $118.97 |
| Revenue Growth | ★ 9.46 | 8.24 |
| 52 Week Low | $31.11 | $158.20 |
| 52 Week High | $52.45 | $231.82 |
| Indicator | SLB | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 32.90 | 23.13 |
| Support Level | $32.81 | N/A |
| Resistance Level | $52.17 | $195.22 |
| Average True Range (ATR) | 1.65 | 4.18 |
| MACD | -0.77 | -1.05 |
| Stochastic Oscillator | 12.47 | 3.91 |
SLB is the world's premier oilfield-services company as measured by market share. While the industry is largely fragmented, SLB holds the first or second competitive position in many of the differentiated oligopolies in which it operates. Also known as Schlumberger, the company was founded in 1926 by two brothers bearing the same last name. Today, it's most known as a global industry leader in innovation, while it focuses its strategy on its three growth engines: core, digital, and new energy businesses. Over three-fourths of its revenue base is tied to international markets, while the company boasts nearly $3 billion in digital-related revenue.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.